News Coverage 10.27.20 Share on Twitter Share on Facebook Share on LinkedIn Putting AI in R&D The use of artificial intelligence in drug discovery is becoming increasingly common at Big Pharma and little biotech alike. We’ll talk to several leaders in the AI field to learn about some examples of their work. Can they speed the development of more drugs with better odds… Related Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer Announcement, Press Release Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science
Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science